China Universal Asset Management Co., Ltd. Intellia Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 19,537 shares of NTLA stock, worth $237,960. This represents 0.04% of its overall portfolio holdings.
Number of Shares
19,537
Previous 11,333
72.39%
Holding current value
$237,960
Previous $253,000
58.5%
% of portfolio
0.04%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding NTLA
# of Institutions
314Shares Held
91.5MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$149 Million2.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.63MShares$117 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$117 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$62.6 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$60.3 Million3.75% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $926M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...